Document




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
_______________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 29, 2019
_______________
CYRUSONE INC.
(Exact Name of Registrant as Specified in its Charter)
_______________
Maryland
 
001-35789
 
46-0691837
(State of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
2101 Cedar Springs Road, Suite 900
Dallas, TX 75201
(Address of Principal Executive Office)
Registrant’s telephone number, including area code: (972) 350-0060
_______________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨







Item 5.07    Submission of Matters to a Vote of Security Holders.
CyrusOne Inc. (the “Company”) held its 2019 Annual Meeting of Stockholders on April 29, 2019. The final voting results are set forth below.
Proposal 1: The stockholders elected each of the eight director nominees to the Board of Directors of the Company to serve until the 2020 Annual Meeting of Stockholders, as follows:
 
 
Votes For
 
Votes Withheld
 
Broker Non-Votes
David H. Ferdman
 
90,505,787

 
564,112

 
5,846,448

John W. Gamble, Jr.
 
90,548,342

 
521,557

 
5,846,448

Michael A. Klayko
 
88,773,394

 
2,296,505

 
5,846,448

T. Tod Nielsen
 
89,144,060

 
1,925,839

 
5,846,448

Alex Shumate
 
89,795,408

 
1,274,491

 
5,846,448

William E. Sullivan
 
89,187,838

 
1,882,061

 
5,846,448

Lynn A. Wentworth
 
88,565,827

 
2,504,072

 
5,846,448

Gary J. Wojtaszek
 
90,546,200

 
523,699

 
5,846,448

Proposal 2: The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
78,679,635
 
12,297,978
 
92,280
 
5,846,454
Proposal 3: The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019, as follows:
Votes For
 
Votes Against
 
Abstentions
 
Broker Non-Votes
96,562,640
 
268,919
 
84,788
 
0





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
Date: April 30, 2019
 
CYRUSONE INC.
 
 
 
 
 
By:
 
/s/ Robert M. Jackson
 
 
 
 
Robert M. Jackson
 
 
 
 
Executive Vice President, General Counsel
 
 
 
 
and Secretary